According to the 2016 ACC/AHA guidelines, which medications should be included in a dual antiplatelet therapy (DAPT) regimen in the treatment of myocardial infarction (MI, heart attack)?

Updated: May 07, 2019
  • Author: A Maziar Zafari, MD, PhD, FACC, FAHA; Chief Editor: Eric H Yang, MD  more...
  • Print

In 2016, the American College of Cardiology and American Heart Association (ACC/AHA) released updated guidelines on duration of dual antiplatelet therapy (DAPT) in patients with coronary artery disease. [134] In this focused update, the term and acronym DAPT is used to specifically to refer to combination antiplatelet therapy with aspirin and a P2Y12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!